Steven Cohen’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
DTC
BBA
Steven Cohen's DSGN Position: Q3 2026 in Review
Steven Cohen reduced its Design Therapeutics (DSGN) stake by 2.1% in Q3 2026, selling an estimated $674K and leaving 2,317,682 shares worth $29.1M. The position accounts for 0.03% of the portfolio, ranked #691.
Steven Cohen first reported a position in DSGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $50.4M in Q4 2025. 141 funds tracked by Wall St. Rank hold DSGN as of Q3 2026.
- Steven Cohen held 2,317,682 shares of Design Therapeutics worth $29.1M as of Q3 2026.
- Steven Cohen sold 48,771 Design Therapeutics shares in Q3 2026, an estimated $674K.
- Design Therapeutics made up 0.03% of Steven Cohen's portfolio in Q3 2026, its #691 holding.
- Steven Cohen first reported a position in Design Therapeutics in Q1 2023 and has held it in 14 quarters since.
- Steven Cohen's Design Therapeutics position peaked at $50.4M in Q4 2025.
- 141 funds tracked by Wall St. Rank held Design Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.